ICU Medical, Inc.
US ˙ NasdaqGS ˙ US44930G1076

SecurityICUI / ICU Medical, Inc.
InstitutionLazard Asset Management Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Lazard Asset Management Llc closes position in ICUI / ICU Medical, Inc.

On November 14, 2025 - Lazard Asset Management Llc filed a 13F-HR form disclosing ownership of 0 shares of ICU Medical, Inc. (US:ICUI) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 10,376 shares of ICU Medical, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F ICU MED Common Stock 44930G107 0 -10,376 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ICU MED Common Stock 44930G107 10,376 10,312 16,112.50 1 0.0019
2025-05-15 2025-03-31 13F ICU MED Common Stock 44930G107 64 -10 -13.51 0 0.0000
2025-02-14 2024-12-31 13F ICU MED Common Stock 44930G107 74 -1,886 -96.22 0 0.0000
2024-11-14 2024-09-30 13F ICU MED Common Stock 44930G107 1,960 883 81.99 0 0.0005
2024-08-14 2024-06-30 13F ICU MED Common Stock 44930G107 1,077 491 83.79 0 0.0002
2024-07-09 2024-03-31 13F/A-1 ICU MED Common Stock 44930G107 586 32 5.78 0 0.0001
2024-05-14 2024-03-31 13F ICU MED Common Stock 44930G107 586 32 0 0.0001
2024-02-14 2023-12-31 13F ICU MED Common Stock 44930G107 554 -21 -3.65 0 0.0001
2023-11-14 2023-09-30 13F ICU MED Common Stock 44930G107 575 575 0 0.0001
2022-11-14 2022-09-30 13F ICU MED Common Stock 44930G107 0 -16 -100.00 0 -100.00
2022-08-09 2022-06-30 13F ICU MED Common Stock 44930G107 16 -28,243 -99.94 2 -99.97 0.0000
2022-05-13 2022-03-31 13F ICU MED Common Stock 44930G107 28,259 28,158 27,879.21 6,291 27,252.17 0.0073
2022-02-09 2021-12-31 13F ICU MED Common Stock 44930G107 101 101 23 0.0000
2019-11-14 2019-09-30 13F ICU MED Common Stock 44930G107 0 -79,600 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ICU MED Common Stock 44930G107 79,600 -1,800 -2.21 20,052 2.93 0.0325
2019-08-28 2019-03-31 13F/A-1 ICU MED Common Stock 44930G107 81,400 81,400 19,481 0.0319
2019-05-13 2019-03-31 13F ICU MED Common Stock 44930G107 81,400 19,481
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.